(Reuters) - Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient access and available ...

After she was diagnosed at age 48 with Type 1 diabetes, Stacey Silverman muddled through her days with high blood sugar, fatigue and splitting headaches. Taking a long-acting form of insulin called ...

Insulin is an essential medicine that helps the body turn food into energy and regulate blood sugar levels for millions of people with diabetes nationwide. That makes access to insulin vital for ...

Levemir, one of the three types of long-acting basal insulins, is evacuating the U.S. market, and diabetes patient advocates told USA Today they’re worried about using a new medication after nearly ...

Biden administration launches partnership with Instacart; critics raise concerns over pharmaceutical industry influence in negotiations; patients seek alternatives as Novo Nordisk halts insulin ...

Levemir (insulin detemir) is safe to receive while pregnant or breastfeeding. However, factors such as the form you get or the condition the drug helps treat may determine whether you should receive ...

VIENNA (Reuters) - Novo Nordisk's Levemir was not associated in any increase in incidence of cancer when compared with human insulin in studies including some 9,000 patients, according to a new ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Novo Nordisk logo above the entrance to their offices in Copenhagen (Reuters) - Novo Nordisk said on Wednesday it ...